Core Viewpoint - The legal opinion letter from Zhejiang Tiance Law Firm confirms the legality and validity of the procedures and results of the annual general meeting of Tongce Medical Co., Ltd. for 2024 [1][2][6] Group 1: Meeting Procedures - The annual general meeting was proposed and convened by the board of directors, with the notice published on May 15, 2025 [2][3] - The meeting utilized a combination of on-site and online voting, with the on-site meeting scheduled for June 5, 2025, at 14:30 [2][3] - The online voting period was set for June 5, 2025, from 9:15 to 15:00 [3] Group 2: Attendance and Voting - Attendees included all registered shareholders from the Shanghai branch, with the option to appoint proxies who do not need to be shareholders [3][4] - A total of 3 individuals attended the meeting in person, representing 159,642,160 shares, approximately 35.6910% of the total share capital [4] - The total number of participants in the voting, including both on-site and online, was 595, representing 163,400,082 shares, approximately 36.5312% of the total share capital [4] Group 3: Voting Results - The voting process adhered to legal and regulatory requirements, with results announced on-site without objections from attendees [6] - The voting results for various proposals showed overwhelming support, with approval rates ranging from 99.7317% to 99.7649% [5][6] - The meeting did not vote on any matters not listed in the notice [6] Group 4: Conclusion - The legal opinion concludes that the meeting's convening, attendance qualifications, and voting procedures complied with relevant laws and regulations, confirming the validity of the voting results [6]
通策医疗: 浙江天册律师事务所关于通策医疗股份有限公司2024年年度股东大会的法律意见书